Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy (Q39806537)

14 September 2017

Targeted hepatocellular carcinoma proapoptotic BikDD gene therapy (English)

1 reference

14 September 2017

0 references

L-Y Li

1

1 reference

14 September 2017

H-Y Dai

2

1 reference

14 September 2017

F-L Yeh

3

1 reference

14 September 2017

S-F Kan

4

1 reference

14 September 2017

J Lang

5

1 reference

14 September 2017

J L Hsu

6

1 reference

14 September 2017

L-B Jeng

7

1 reference

14 September 2017

Y-H Chen

8

1 reference

14 September 2017

Y-P Sher

9

1 reference

14 September 2017

W-C Lin

10

1 reference

14 September 2017

M-C Hung

11

1 reference

14 September 2017

language of work or name

English

0 references

publication date

13 December 2010

1 reference

14 September 2017

1 reference

14 September 2017

30

1 reference

14 September 2017

15

1 reference

14 September 2017

1773-1783

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2010.558

14 September 2017

0 references

cites work

Cellular aspects of alpha-fetoprotein reexpression in tumors

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

New therapies for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Cancer-specific activation of the survivin promoter and its potential use in gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Hepatocellular carcinoma: epidemiology and molecular carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Hepatocellular carcinoma: summary and recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Gene expression profiling of preneoplastic liver disease and liver cancer: a new era for improved early detection and treatment of these deadly diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Expression liver-directed genes by employing synthetic transcriptional control units

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Therapeutic effect of alpha-fetoprotein promoter-mediated tBid and chemotherapeutic agents on orthotopic liver tumor in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

A position-dependent silencer plays a major role in repressing alpha-fetoprotein expression in human hepatoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Global cancer statistics, 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

A tumor-specific conditionally replicative adenovirus vector expressing TRAIL for gene therapy of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Liver pathology in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

E1B-55K-deleted adenovirus expressing E1A-13S by AFP-enhancer/promoter is capable of highly specific replication in AFP-producing hepatocellular carcinoma and eradication of established tumor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Improved DNA: liposome complexes for increased systemic delivery and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

A novel hTERT promoter-driven E1A therapeutic for ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Alpha-fetoprotein production by hepatocellular carcinoma is prognostic of poor patient survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Prognostic factors in unresectable hepatocellular cancer: Radiation therapy oncology group study 83-01

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Targeted expression of BikDD eradicates pancreatic tumors in noninvasive imaging models

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2010.558

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/ONC.2010.558

1 reference

14 September 2017

1 reference